Accueil   Diary - News   All news NH TherAguix

NH TherAguix

 

Nanoparticles for theranostic, combining imaging and therapy

“See what to target, target what to see”



NH TherAguix, new Lyonbiopole's company member, is a clinical stage pharmaceutical company developing innovative nanomedicine that improve radiation therapy benefits without modifying current clinical workflows. Our leading product, AGuIX®, is a nanoparticle designed to improve the localization of solid tumors and the outcomes of radiation therapy by a unique intravenous injection.



Read the press release

 

 

Afficher l'image d'origine